RhythmAnalytics vs Reveal LINQ Insertable Cardiac Monitor

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by Biofourmis Singapore Pte.
VS

AI Verdict

RhythmAnalytics is a cloud-based AI software designed for automated interpretation of cardiac arrhythmias from various external ECG devices, offering clinical decision support. In contrast, the Reveal LINQ Insertable Cardiac Monitor is an implantable device with integrated AI algorithms for long-term, continuous subcutaneous ECG monitoring, specifically focused on reducing false alerts. While both leverage AI for cardiac rhythm analysis and diagnosis, they differ significantly in their deployment (software vs. implantable hardware) and primary use case (interpretation of diverse ECG data vs. proprietary long-term monitoring).

Choose RhythmAnalytics if…

Choose RhythmAnalytics if you need an AI-powered, cloud-based solution to rapidly interpret cardiac arrhythmias from existing single-lead ECG data sources, such as Holter monitors or wearable sensors. This tool is ideal for integrating automated arrhythmia detection and clinical decision support directly into your current diagnostic workflows or for processing data from a diverse range of FDA-cleared ECG devices.

View RhythmAnalytics →

Choose Reveal LINQ Insertable Cardiac Monitor if…

Choose the Reveal LINQ Insertable Cardiac Monitor if your patient requires long-term, continuous cardiac monitoring (up to 4.5 years) for infrequent or unexplained symptoms like syncope or palpitations, where a definitive diagnosis has been challenging with external monitoring. This implantable device, with its AccuRhythm AI algorithms, is specifically designed to reduce false alerts and enhance the diagnostic yield for conditions like atrial fibrillation over an extended period.

View Reveal LINQ Insertable Cardiac Monitor →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature RhythmAnalytics Reveal LINQ Insertable Cardiac Monitor
Pricing Contact vendor Contact vendor
Deployment Cloud-based API Implantable device with data transmitted to a cloud-based platform (CareLink™ network) via patient smartphone app or home communicator.
BAA Available Unknown Yes AI-estimated
FDA Status Cleared AI-estimated Yes AI-estimated
HIPAA Yes AI-estimated Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

RhythmAnalytics

RhythmAnalytics (Tool A) is a cloud-based API designed for integration into existing clinical workflows, offering a potentially more seamless experience for healthcare professionals. Reveal LINQ ICM (Tool B) involves an implantable device and a patient-facing app, which introduces additional steps for patient management and device interaction, making its overall system usability more complex for clinicians despite the patient app's ease of use for data transmission.

Clinical Value

Reveal LINQ Insertable Cardiac Monitor

Reveal LINQ ICM (Tool B) provides continuous, long-term monitoring for up to 4.5 years and uses AccuRhythmu2122 AI to significantly reduce false alerts, thereby enhancing diagnostic yield for elusive conditions like AFib and syncope. While RhythmAnalytics (Tool A) offers automated interpretation of various arrhythmias, Tool B's focus on improving the accuracy and longevity of data collection directly addresses a critical pain point in cardiac diagnostics.

Pricing & Value

Reveal LINQ Insertable Cardiac Monitor

Both tools require direct vendor contact for pricing, making a direct cost comparison difficult. However, Tool B explicitly states it has a Business Associate Agreement (BAA), which is a crucial component for healthcare organizations handling Protected Health Information (PHI) and adds significant value from a compliance and trust perspective. Tool A's BAA status is unspecified in the provided facts.

Enterprise Readiness

Reveal LINQ Insertable Cardiac Monitor

Tool B demonstrates stronger enterprise readiness by explicitly confirming a Business Associate Agreement (BAA), which is essential for healthcare organizations to ensure HIPAA compliance and secure data handling. While Tool A offers a cloud-based API for integration, the lack of specified BAA in its description presents a potential hurdle for enterprise adoption.

Innovation

Reveal LINQ Insertable Cardiac Monitor

Tool B's AccuRhythmu2122 AI algorithms, specifically designed to reduce false alerts in an implantable cardiac monitor, represent a significant innovation in improving the accuracy and efficiency of long-term cardiac monitoring. This, combined with its 4.5-year battery longevity and MRI compatibility, addresses key challenges in device-based diagnostics. Tool A's automated interpretation is valuable but represents a more established application of AI in ECG analysis.

Support & Docs

Reveal LINQ Insertable Cardiac Monitor

Medtronic (Tool B) provides extensive and readily accessible support resources and documentation for the Reveal LINQ ICM, including clinician manuals, patient guides, and dedicated technical and patient service lines. Biofourmis (Tool A), while likely offering support for its enterprise solutions, does not have as publicly detailed or comprehensive documentation specifically for RhythmAnalytics.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature RhythmAnalytics Reveal LINQ Insertable Cardiac Monitor
Name RhythmAnalytics Reveal LINQ Insertable Cardiac Monitor
Company Biofourmis Singapore Pte. Medtronic
Description Summary FDA-cleared, AI-powered cloud-based software that provides automated interpretation of cardiac arrhythmias from single-lead ECG data, offering clinical decision support. Insertable Cardiac Monitor (ICM) with AccuRhythmu2122 AI algorithms for long-term, accurate heart monitoring, reducing false alerts and enhancing diagnostic yield.
Tagline AI-powered automated interpretation of cardiac arrhythmias for enhanced clinical decision support. Accuracy matters.
Primary Output/Monitoring Automated interpretation of over 15 types of cardiac arrhythmias, beat-by-beat morphology computation, ECG signal processing, QRS and Ventricular Ectopic Beat detection, interval/heart rate measurement, and rhythm analysis. Continuous, long-term subcutaneous ECG monitoring with reduced false alerts (AF and Pause).
AI Algorithm Focus AI-based automated interpretation of cardiac arrhythmias. AccuRhythmu2122 AI algorithms for reduced false alerts (AF and Pause) using deep learning AI.

Videos

Demos, reviews, and walkthroughs featuring RhythmAnalytics and Reveal LINQ Insertable Cardiac Monitor.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

RhythmAnalytics by Biofourmis is a cloud-based software that provides automated interpretation of cardiac arrhythmias from single-lead ECG data, which is compatible with FDA-cleared external ECG devices. In contrast, the Reveal LINQ Insertable Cardiac Monitor is an implantable device that provides continuous, long-term subcutaneous ECG monitoring.
RhythmAnalytics offers AI-powered automated interpretation of cardiac arrhythmias, providing clinical decision support for healthcare professionals. The Reveal LINQ ICM focuses on long-term, accurate heart monitoring, utilizing AI to reduce false alerts and enhance diagnostic yield for conditions like atrial fibrillation and syncope.
RhythmAnalytics' AI is designed for automated interpretation and detection of over 15 types of cardiac arrhythmias, including beat-by-beat morphology computation and rhythm analysis. The Reveal LINQ ICM's AccuRhythm AI algorithms are specifically engineered to reduce false alerts for atrial fibrillation and pauses, thereby enhancing diagnostic yield.
RhythmAnalytics is used for interpreting existing or incoming single-lead ECG data from other devices, suggesting an on-demand or event-based analysis. The Reveal LINQ ICM provides continuous, long-term subcutaneous ECG monitoring with a battery longevity of 4.5 years (nominal settings).
RhythmAnalytics is applicable across Cardiology, Emergency Medicine, and Internal Medicine. The Reveal LINQ ICM is primarily intended for Cardiology and Pediatrics.
RhythmAnalytics is designed for the automated interpretation and detection of over 15 types of cardiac arrhythmias. The Reveal LINQ ICM is indicated for patients at increased risk of cardiac arrhythmias and those experiencing transient symptoms such as dizziness, palpitations, syncope, and chest pain, with a focus on enhancing diagnostic yield for conditions like atrial fibrillation and syncope.
AI Tool Finder
AI-powered search. Results may not be comprehensive.